US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Erythromycin 2% in Cerave Cream

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0536-2017
Class II · Moderate risk Terminated

Clobetasol 0.05% in Olea Base

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0535-2017
Class II · Moderate risk Terminated

Clindamycin 1%

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0534-2017
Class II · Moderate risk Terminated

Bleaching Cream 0.1% Cream

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0533-2017
Class II · Moderate risk Terminated

Bl 20%/4% Cream

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0532-2017
Class II · Moderate risk Terminated

Benzoyl Peroxide 5% Clindamycin 1.2%

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0531-2017
Class II · Moderate risk Terminated

Adapalene 0.1%

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0530-2017
Class II · Moderate risk Terminated

Bicarbonate 10%

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0529-2017
Class II · Moderate risk Terminated

MINOXADIL all strength including 2%

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0528-2017
Class II · Moderate risk Terminated

5-Fluorouracil in Vanicream

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0527-2017
Class II · Moderate risk Terminated

Human Chorionic Gonadotropin

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0522-2017
Class II · Moderate risk Terminated

METRONIDazole Injection

Reason Lack of Sterility Assurance: customer report of leaking bag

Hospira Inc., A Pfizer Company NDC 0409-7811-24 D-0480-2017
Class I · High risk Terminated

Ibuprofen Lysine Injection

Reason Presence of Particulate Matter

X-Gen Pharmaceuticals Inc. NDC 39822-1030-1 D-0637-2017
Class II · Moderate risk Terminated

CycloSPORINE Capsules

Reason Failed Impurities/Degradations Specifications; out of specification results for Maximum Unknown Impurities and Total Impurities

Amerisource Health Services NDC 68084-921-25 D-0490-2017
Class III · Low risk Terminated

Levofloxacin Ophthalmic Solution

Reason Failed Impurities/ Degradation Specifications: OOS for related compound (levofloxacin n-oxide) at the 18 month stability time point.

Actavis Inc NDC 50383-283-05 D-0514-2017
Class II · Moderate risk Terminated

Indocin

Reason Failed Impurities/Degradation Specifications: Out of specification (OOS) for total impurity and out of trend for known impurity results encountered during stability testing.

G & W Laboratories, Inc. NDC 42211-0102-43 D-0501-2017
Class II · Moderate risk Terminated

Glipizide 2.5 mg ER Tablets

Reason Failed Dissolution Specifications

RemedyRepack Inc. NDC 52125-0764-02 D-0482-2017
Class I · High risk Terminated

Vancomycin HCl 750 mg added to 5% Dextrose 250 mL For IV Use Only

Reason Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.

SCA Pharmaceuticals NDC 70004-0918-40 D-0645-2017